Dehns is now member of the Oslo Cancer Cluster
Dehns Patent and Trade Mark Attorneys recently joined the Oslo Cancer Cluster.
Dehns is one of Europe’s largest firms of patent and trade mark attorneys and has a 40 year history of working with Norwegian organisations such as: Dynal, Inven2,Lytix Biopharma, Nextera, NMBU, NTNU, Nycomed, PCI Biotech and Photocure.
As members, our aim is to advise and help protect the other members needs regarding innovations and intellectual property (IP) around cancer research, diagnosis and treatment.
With experts in this field, many of whom also have PhDs, we can help you build and manage your IP portfolio and strategy, including providing advice on the patentability of inventions, draft and file patent applications, represent you in opposition and other contentious proceedings, as well as advise on academia-industry collaborations and licensing agreements.
